Medical Research
(H30)
IRS Verified
DX Registered
ROYAL DAMES OF CANCER RESEARCH INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$665K
Total Revenue
$649K
Total Expenses
$32K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
94.8%
Fundraising Efficiency
0.0%
Operating Reserve
0.60x
Liability-to-Asset
0.0%
Revenue Diversification
100.0%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $665K | $649K | $32K | 94.8% | 0 |
| 2022 | $736K | $710K | N/A | — | 0 |
| 2021 | $416K | $427K | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.